ValuEngine upgraded shares of Nu Skin Enterprises (NYSE:NUS) from a hold rating to a buy rating in a research report released on Friday, February 2nd.
NUS has been the topic of several other reports. Zacks Investment Research lowered Nu Skin Enterprises from a buy rating to a hold rating in a research report on Thursday, October 5th. Citigroup reiterated a buy rating and set a $81.00 price objective (up from $70.00) on shares of Nu Skin Enterprises in a research report on Tuesday, January 23rd. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company. The company currently has a consensus rating of Hold and a consensus price target of $65.38.
Nu Skin Enterprises (NYSE:NUS) opened at $68.25 on Friday. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $3,559.14, a PE ratio of 23.89, a PEG ratio of 2.10 and a beta of 1.46. Nu Skin Enterprises has a 1 year low of $47.10 and a 1 year high of $74.45.
In related news, Chairman Steven Lund sold 108,132 shares of the stock in a transaction dated Friday, December 22nd. The stock was sold at an average price of $68.81, for a total transaction of $7,440,562.92. Following the completion of the sale, the chairman now directly owns 4,769 shares in the company, valued at approximately $328,154.89. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold a total of 195,978 shares of company stock valued at $13,512,733 over the last 90 days. 5.20% of the stock is currently owned by company insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Cerebellum GP LLC purchased a new stake in Nu Skin Enterprises in the 4th quarter worth approximately $124,000. Migdal Insurance & Financial Holdings Ltd. purchased a new stake in Nu Skin Enterprises in the 3rd quarter worth approximately $148,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Nu Skin Enterprises by 38.6% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,082 shares of the company’s stock worth $210,000 after buying an additional 858 shares during the period. Dynamic Technology Lab Private Ltd purchased a new stake in Nu Skin Enterprises in the 3rd quarter worth approximately $219,000. Finally, Virtu Financial LLC purchased a new position in shares of Nu Skin Enterprises in the 4th quarter valued at approximately $220,000. Institutional investors and hedge funds own 77.00% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/13/nu-skin-enterprises-nus-rating-increased-to-buy-at-valuengine.html.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.